BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/15/2026 9:33:29 AM | Browse: 17 | Download: 1
Publication Name World Journal of Critical Care Medicine
Manuscript ID 124802
DOI 10.5492/wjccm.124802
Country United States
Category Critical Care Medicine
Manuscript Type Retrospective Cohort Study
Article Title Use of reversal agents for factor xa inhibitors and progression of traumatic intracranial hemorrhage: A propensity matched analysis
Manuscript Source Unsolicited Manuscript
All Author List Benjamin O’Brien, Weng Chan, Larissa Russo and Nasim Ahmed
Funding Agency and Grant Number
Corresponding Author Nasim Ahmed, FACS, Full Professor, Department of Surgery, Division of Trauma and Surgical Critical Care, Jersey Shore University Medical Center, 1945 State Rt. 33, Neptune, NJ 07753, United States. nasim.ahmed@hmhn.org
Key Words Traumatic intracranial hemorrhage; Factor Xa inhibitors; Four-factor prothrombin complex concentrate; Andexanet alfa; Progression of hemorrhage
Core Tip The purpose of the study was to assess which reversal agent, four-factor prothrombin complex concentrate or andexanet alfa, had a better effect on expansion of intracranial hemorrhage (ICH) in patients who received direct oral anticoagulants. Andexanet alfa was found to have better effect on expansion of ICH (25.5% vs 41.2%, P = 0.226), however statistically found no difference. Larger sample size studies are needed to determine which reversal agent has better efficacy in preventing expansion of traumatic ICH.
Citation O’Brien B, Chan W, Russo L, Ahmed N. Use of reversal agents for factor xa inhibitors and progression of traumatic intracranial hemorrhage: A propensity matched analysis. World J Crit Care Med 2026; In press
PDF 124802-in-press.pdf
Received
2026-06-24 07:38
Peer-Review Started
2026-06-24 07:39
First Decision by Editorial Office Director
Return for Revision
2026-07-21 02:48
Revised
2026-08-04 12:45
Publication Fee Transferred
Second Decision by Editor
2026-09-15 02:45
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-09-15 09:33
Articles in Press
2026-09-15 09:33
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3141(online)
Open Access Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com